[Federal Register Volume 63, Number 19 (Thursday, January 29, 1998)]
[Notices]
[Page 4462]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-2173]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute of Allergy and Infectious Diseases Special Emphasis
Panel (SEP) meetings:
Name of SEP: Laboratory Support for AIDS Vaccine and Other
Prevention Clinical Trials.
Date: February 20, 1998.
Time: 9:00 a.m. to Adjournment.
Place: Solar Building, Room 1A1, 6003 Executive Blvd., Bethesda,
MD 20892, (301) 496-2550.
Contact Person: Dr. Paula Strickland, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., Room 4C02, Bethesda, MD
20892, (301) 402-0643.
Purpose/Agenda: To evaluate contact proposals.
Name of SEP: Preclinical Evaluation of Therapies for Treatment
of Cryptococcosis.
Date: February 27, 1998.
Time: 8:30 a.m. to Adjournment.
Place: Bethesda Ramada Hotel and Conference Room, Parlor Room,
8400 Wisconsin Avenue, Bethesda, MD 20814, (301) 654-1000.
Contact Person: Dr. Vassil Georgiev, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., Room 4C04, Bethesda, MD
20892, (301) 496-8206.
Purpose/Agenda: To evaluate contract proposals.
These meetings will be closed in accordance with the provisions
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.855,
Immunology, Allergic and Immunologic Diseases Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health)
Dated: January 22, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-2173 Filed 1-28-98; 8:45 am]
BILLING CODE 4140-01-M
